157 related articles for article (PubMed ID: 24680582)
41. Using Misoprostol for Primary versus Secondary Prevention of Postpartum Haemorrhage - Do Costs Matter?
Chatterjee S; Sarkar A; Rao KD
PLoS One; 2016; 11(10):e0164718. PubMed ID: 27755601
[TBL] [Abstract][Full Text] [Related]
42. Misoprostol for postpartum hemorrhage: moving from evidence to practice.
Starrs A; Winikoff B
Int J Gynaecol Obstet; 2012 Jan; 116(1):1-3. PubMed ID: 22078140
[TBL] [Abstract][Full Text] [Related]
43. Barriers or gaps in implementation of misoprostol use for post-abortion care and post-partum hemorrhage prevention in developing countries: a systematic review.
Samnani AABA; Rizvi N; Ali TS; Abrejo F
Reprod Health; 2017 Oct; 14(1):139. PubMed ID: 29078777
[TBL] [Abstract][Full Text] [Related]
44. Civil Society Organizations and medicines policy change: a case study of registration, procurement, distribution and use of misoprostol in Uganda.
Atukunda EC; Brhlikova P; Agaba AG; Pollock AM
Soc Sci Med; 2015 Apr; 130():242-9. PubMed ID: 25728484
[TBL] [Abstract][Full Text] [Related]
45. Home use of misoprostol to prevent PPH. Editor's Comment.
Fortney JA
Int J Gynaecol Obstet; 2010 Mar; 108(3):268. PubMed ID: 20053401
[No Abstract] [Full Text] [Related]
46. Cost-effectiveness of misoprostol to control postpartum hemorrhage in low-resource settings.
Bradley SE; Prata N; Young-Lin N; Bishai DM
Int J Gynaecol Obstet; 2007 Apr; 97(1):52-6. PubMed ID: 17316646
[TBL] [Abstract][Full Text] [Related]
47. Prevention of postpartum haemorrhage by community-based auxiliary midwives in hard-to-reach areas of Myanmar: a qualitative inquiry into acceptability and feasibility of task shifting.
Than KK; Mohamed Y; Oliver V; Myint T; La T; Beeson JG; Luchters S
BMC Pregnancy Childbirth; 2017 May; 17(1):146. PubMed ID: 28514959
[TBL] [Abstract][Full Text] [Related]
48. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial.
Derman RJ; Kodkany BS; Goudar SS; Geller SE; Naik VA; Bellad MB; Patted SS; Patel A; Edlavitch SA; Hartwell T; Chakraborty H; Moss N
Lancet; 2006 Oct; 368(9543):1248-53. PubMed ID: 17027730
[TBL] [Abstract][Full Text] [Related]
49. Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage.
Nasr A; Shahin AY; Elsamman AM; Zakherah MS; Shaaban OM
Int J Gynaecol Obstet; 2009 Jun; 105(3):244-7. PubMed ID: 19249048
[TBL] [Abstract][Full Text] [Related]
50. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women.
Chaudhuri P; Biswas J; Mandal A
Int J Gynaecol Obstet; 2012 Feb; 116(2):138-42. PubMed ID: 22100204
[TBL] [Abstract][Full Text] [Related]
51. Misoprostol for postpartum haemorrhage.
Drug Ther Bull; 2010 Jun; 48(6):66-9. PubMed ID: 20530028
[TBL] [Abstract][Full Text] [Related]
52. Helping rural women in Pakistan to prevent postpartum hemorrhage: a quasi experimental study.
Mir AM; Wajid A; Gull S
BMC Pregnancy Childbirth; 2012 Oct; 12():120. PubMed ID: 23110458
[TBL] [Abstract][Full Text] [Related]
53. Misoprostol for the management of postpartum haemorrhage.
Elati A; Weeks A
BMJ; 2011 May; 342():d2877. PubMed ID: 21571915
[No Abstract] [Full Text] [Related]
54. Reducing postpartum hemorrhage in Africa.
Lazarus JV; Lalonde A
Int J Gynaecol Obstet; 2005 Jan; 88(1):89-90. PubMed ID: 15617720
[TBL] [Abstract][Full Text] [Related]
55. Challenges and Successes of Distributing Birth Kits with Misoprostol to Reduce Maternal Mortality in Rural Tanzania.
Webber GC; Chirangi BM; Magatti NJ
Afr J Reprod Health; 2019 Sep; 23(3):68-78. PubMed ID: 31782633
[TBL] [Abstract][Full Text] [Related]
56. Social networks and health policy: the case of misoprostol and the WHO model essential medicine list.
Millard C; Brhlikova P; Pollock A
Soc Sci Med; 2015 May; 132():190-6. PubMed ID: 25818380
[TBL] [Abstract][Full Text] [Related]
57. Is Misoprostol Equivalent to Oxytocin for Postpartum Hemorrhage?
Chireau MV
Issues Law Med; 2015; 30(2):217-25. PubMed ID: 26710381
[No Abstract] [Full Text] [Related]
58. Oral misoprostol for prevention of postpartum hemorrhage by paramedical workers in India.
Chandhiok N; Dhillon BS; Datey S; Mathur A; Saxena NC
Int J Gynaecol Obstet; 2006 Feb; 92(2):170-5. PubMed ID: 16371228
[TBL] [Abstract][Full Text] [Related]
59. Training traditional birth attendants to use misoprostol and an absorbent delivery mat in home births.
Prata N; Quaiyum MA; Passano P; Bell S; Bohl DD; Hossain S; Azmi AJ; Begum M
Soc Sci Med; 2012 Dec; 75(11):2021-7. PubMed ID: 22921713
[TBL] [Abstract][Full Text] [Related]
60. Implementing at-scale, community-based distribution of misoprostol tablets to mothers in the third stage of labor for the prevention of postpartum haemorrhage in Sokoto State, Nigeria: Early results and lessons learned.
Orobaton N; Abdulazeez J; Abegunde D; Shoretire K; Maishanu A; Ikoro N; Fapohunda B; Balami W; Beal K; Ganiyu A; Gwamzhi R; Austin A
PLoS One; 2017; 12(2):e0170739. PubMed ID: 28234894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
